Stockreport

WPD Pharmaceuticals and CNS Pharmaceuticals Identify Leading Polish Medical Institutions for Berubicin Phase 2 Clinical Trial [Canadian Business Journal (Canada)]

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF VANCOUVER, British Columbia, April 30, 2020 (GLOBE NEWSWIRE) —WPD Pharmaceuticals Inc.“Company”“WPD”CNSGBMThe US Phase 2 trial Sponsor will be CNS and the Polish Phase 2 [Read more]